who should not take semaglutide Cannot for Weight Loss Semaglutide: Double-edged Sword with Risks

This will help you to maintain a decreased appetite to ensure you dont regain the weight

The Brain Effects: Promising, Worrying, and Poorly Understood GLP-1 receptors exist in the brain, not just the gut

doi: 10.3390/nu7020730

Retatrutide trial participants shed 24.2% of their initial weight over 48 weeks, outperforming both tirzepatide and semaglutide

Semaglutide is a GLP-1 receptor agonist, which means it's a medicine that mimics the GLP-1 hormone and binds to receptors

One notable study on the efficacy of oral semaglutide in Japanese individuals with T2D is the PIONEER 9 study ( As demonstrated in this study, GLP-1 RAs are rarely used as monotherapy in real-world clinical practice